Trevor Winter

Back to Profile

Publication Details

  • Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study.

    Winter TA, Wright J, Ghosh S, Jahnsen J, Innes A, Round P. Aliment Pharmacol Ther. 2004; 20 (11-12): 1337-46

    CDP870 is a PEGylated Fab' fragment of a humanized monoclonal antibody that neutralizes tumour necrosis factor-alpha.

    PubMedID: 15606396

Stanford Medicine Resources:

Footer Links: